Introduction
In 1980, Halfdan Mahler, the then Director-General of the WHO, identified surgery as a critical part of primary healthcare and challenged the global health community to address the gross inequities in access to surgical care that were present at that time.1 However, over 30 years later, 5 billion people—a number greater than the world's total population at the time of Mahler's speech—are unable to access safe, affordable surgical and anaesthesia care when needed.1–3 Concerted action from multiple sectors in all countries is required to ensure that the world will have made progress in closing the access gap by 2030.4
Despite clear evidence of the role of surgery in meeting health targets such as reducing maternal and child mortality, surgery was until recently dismissed as a global health priority.5 ,6 Since 1990, non-communicable diseases (NCDs) have attracted only 1.5% of development assistance for health (DAH), and in 2014 funding for health systems strengthening received only 6.4% of donor funds.6 Country-level spending specific to surgical care remains largely untracked,7 but in countries which spend little on health, surgical systems are inadequate for population need.8–10
However, the landscape is shifting. While the Millennium Development Goals (MDGs) focused on interventions to improve the well-being of specific populations, the new Sustainable Development Goals (SDGs) aim to improve the well-being of all of humanity through an integrated set of 17 systematic goals. In this context, new evidence has emerged showing that surgical conditions are responsible for nearly one-third of the world's burden of disease,11 and that providing surgical treatment can be highly cost-effective.12 The Essential Surgery volume of the Third Edition of Disease Control Priorities (DCP-3) identified 44 surgical procedures deemed essential for public health. Authors argued for the early inclusion of surgery within efforts to achieve universal health coverage on the basis of a 10:1 economic benefit: cost ratio.13 Targeted funding towards surgery and anaesthesia will be critical to reaching the health-related SDGs:14 every Global Burden of Disease subcategory requires surgical intervention at least some of the time.15 In completing the ‘unfinished business’ of the maternal health agenda,16 achieving further reductions in child mortality, eliminating extreme poverty, treating the growing burden of NCDs or simply ensuring healthy lives, investing in surgery is imperative.
On 6 May 2015, representatives from around the world gathered in Boston, Massachusetts, for the North American launch of the Lancet Commission on Global Surgery. This launch followed an 18-month research and consensus-building process involving collaborators in over 110 countries. The purpose of this event was twofold: to bring the findings of the Commission to the attention of high income country (HIC) clinicians and policymakers, and to discuss a multicountry, multisectoral approach to improving access to surgery globally.
The launch consisted of panels and presentations addressing the role of various groups: surgical colleges and academic medical centres (AMCs); HIC trainees and training programmes; academia; global health funders; the biomedical devices industry, and news media and advocacy groups. Panelists included members of the global health and global surgery communities, as well as partners in industry, philanthropy and journalism. They represented both HIC and low and middle income country (LMICs) perspectives. This article reviews the relevant literature and provides a unified call to action for each cadre of HIC actors.